Conditional survival after resection of pancreatic cancer: A population-based study

Latenstein, A.; Geest, L. van der; Dam, R. Van; Koerkamp, B. Groot; Hingh, Ignace de; Homs, Marjolein Y.V.; Klaase, J.M.; Bonsing, B.A.; Lemmens, V.E.P.P.; Molenaar, I.; Stommel, Manfred; Busch, O.; Eijck, C. van; Laarhoven, H.W.M. van; Wilmink, J. M.; Besselink, M.

doi:10.1016/j.hpb.2020.04.230

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[16] медиана ОВ (мОВ) пациентов с РПЖ составила 10,4 мес. По данным другого исследования на основе того же регистра [21], частота резекций увеличилась вдвое с 1997 к 2016 г. (8,3% vs 16,6%), больше пациентов стали получать нео-и адъювантную химиотерапию -ХТ (3,0% vs 56,2%).…”

Section: анализ выживаемости при рпжunclassified

How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review

Zhukova,

Bordin,

Dubtsova

et al. 2024

J. Mod. Onco.

View full text Add to dashboard Cite

Pancreatic cancer (PC) is a serious public health problem. The mortality rate of patients with PC remains one of the highest among cancers. Early diagnosis of PC is challenging, so it is often diagnosed in the later stages. Current treatment approaches, including surgery, neoadjuvant and adjuvant chemotherapy, chemoradiotherapy, and supportive care, have demonstrated improved outcomes. A significant problem remains exocrine pancreatic insufficiency (EPI) in patients with PC, which requires enzyme replacement therapy. However, this is not given due attention in the Russian literature. This review addresses the survival trends of patients with PC, current therapies, and enzyme replacement therapy as an integral part of supportive care and improvement of nutritional status; also, the issues of routing patients with PC are addressed. It is emphasized that the diagnosis and treatment of EPI are mandatory to improve and maintain the nutritional status and quality of life; failure to treat EPI renders antitumor treatment ineffective.

show abstract

Section: анализ выживаемости при рпжunclassified